Extended Data Fig. 3: Distribution and performance of each PRS.
From: Polygenic architecture informs potential vulnerability to drug-induced liver injury
a, Distribution of CM-DILI PRSlimited in TAK-875 DILI patients and the tolerances (see Fig. 1 and Supplementary Text). b, AUROC values and their 95% confidence interval for the indicated PRS. c, Histogram of the indicated PRS.
